OPCH Option Care Health, Inc.
Services-Home Health Care Services · Nasdaq · SEC CIK 1014739 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY4.0%
TTM net income YoY2.9%
TTM EPS YoY8.7%
Revenue 3-yr CAGR11.0%
Net income 3-yr CAGR-5.8%
Margins
Gross margin19.1%
Operating margin5.9%
Net margin3.7%
FCF margin4.9%
EBITDA margin7.1%
Returns
ROE16.0%
ROA6.2%
ROIC (approx.)11.2%
Asset turnover1.65x
Leverage & solvency
Liabilities / assets61.9%
Debt / equity0.87x
Current ratio1.54x
Interest coverage6.39x
Cash quality & payout
Operating cash flow / net income1.50x
Accruals ratio-3.1%
Payout ratio—
Capex / revenue0.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $5.65B | $5.00B |
| Cost of revenue | $4.56B | $3.99B |
| Gross profit | $1.09B | $1.01B |
| SG&A expense | $682.45M | $630.25M |
| Operating income | $337.91M | $321.83M |
| Interest expense | $54.56M | $49.03M |
| Pretax income | $282.90M | $283.60M |
| Income tax | $75.31M | $71.78M |
| Net income | $207.59M | $211.82M |
| EBITDA | $405.44M | $382.74M |
| EPS (basic) | 1.28 | 1.23 |
| EPS (diluted) | 1.27 | 1.23 |
| Weighted avg. shares (diluted) | 163.37M | 172.84M |
| Balance sheet | ||
| Cash & equivalents | $232.62M | $412.56M |
| Receivables | $473.57M | $409.73M |
| Inventory | $471.15M | $388.13M |
| Current assets | $1.26B | $1.32B |
| PP&E, net | $139.24M | $127.37M |
| Goodwill | $1.61B | $1.54B |
| Intangibles | $309.18M | $301.01M |
| Total assets | $3.46B | $3.42B |
| Current liabilities | $829.35M | $780.15M |
| Short-term debt | $6.78M | $6.51M |
| Long-term debt | $1.15B | $1.10B |
| Total debt | $1.16B | $1.11B |
| Total liabilities | $2.13B | $2.02B |
| Shareholders' equity | $1.33B | $1.40B |
| Net debt | $928.21M | $698.59M |
| Shares outstanding | 156.86M | 166.26M |
| Cash flow statement | ||
| Operating cash flow | $258.45M | $323.39M |
| Capital expenditure | $41.31M | $35.61M |
| Free cash flow | $217.14M | $287.79M |
| Investing cash flow | -$161.08M | -$36.47M |
| Financing cash flow | -$277.31M | -$218.21M |
| Depreciation & amortization | $67.54M | $60.91M |
| Stock-based compensation | $39.96M | $36.14M |
| Share buybacks | $309.95M | $252.73M |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.